These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 7299243

  • 1. Endogenous accumulation products and serum protein binding in uremia.
    McNamara PJ, Lalka D, Gibaldi M.
    J Lab Clin Med; 1981 Nov; 98(5):730-40. PubMed ID: 7299243
    [Abstract] [Full Text] [Related]

  • 2. Correction of protein binding defect in uremic sera by charcoal treatment.
    Craig WA, Evenson MA, Sarver KP, Wagnild JP.
    J Lab Clin Med; 1976 Apr; 87(4):637-47. PubMed ID: 1270877
    [Abstract] [Full Text] [Related]

  • 3. Inability of accumulated metabolic byproducts of uremia to alter the extent of warfarin binding in charcoal treated plasma.
    Bachmann K, Conway P, Shapiro R.
    Res Commun Chem Pathol Pharmacol; 1978 Apr; 20(1):117-30. PubMed ID: 663394
    [Abstract] [Full Text] [Related]

  • 4. Effects of the oral adsorbent AST-120 on tryptophan metabolism in uremic patients.
    Tsubakihara Y, Takabatake Y, Oka K, Shoji T, Togawa M, Okada N, Takahito I, Imai E.
    Am J Kidney Dis; 2003 Mar; 41(3 Suppl 1):S38-41. PubMed ID: 12612950
    [Abstract] [Full Text] [Related]

  • 5. Reduced in vitro displacement of valproic acid from protein binding by salicylate in uremic sera compared with normal sera. Role of uremic compounds.
    Dasgupta A, Jacques M.
    Am J Clin Pathol; 1994 Mar; 101(3):349-53. PubMed ID: 8135194
    [Abstract] [Full Text] [Related]

  • 6. Serum protein binding of drugs during and after pregnancy in rats.
    Stock B, Dean M, Levy G.
    J Pharmacol Exp Ther; 1980 Feb; 212(2):264-8. PubMed ID: 7351638
    [Abstract] [Full Text] [Related]

  • 7. Middle molecules in uremic serum, urine and dialysis fluid.
    Migone L, Dall'taglio P, Buzio C.
    Clin Nephrol; 1975 Feb; 3(3):82-93. PubMed ID: 1139803
    [Abstract] [Full Text] [Related]

  • 8. Effects of carbamylation of plasma proteins and competitive displacers on drug binding in uremia.
    Calvo R, Carlos R, Erill S.
    Pharmacology; 1982 Feb; 24(4):248-52. PubMed ID: 7089046
    [Abstract] [Full Text] [Related]

  • 9. [Study of the binding characteristics of chlorophenoxyisobutyric acid to serum proteins in chronically uremic patients : influence of dialysis and heparine (author's transl)].
    Lacour B, Di Giulio S, Nicolaï A, Drüeke T, Debray M, Boulu RG.
    Nephrologie; 1982 Feb; 3(1):19-22. PubMed ID: 7088259
    [Abstract] [Full Text] [Related]

  • 10. Valproate plasma protein binding in the uremic condition.
    Brewster D, Muir NC.
    Clin Pharmacol Ther; 1980 Jan; 27(1):76-82. PubMed ID: 6985855
    [Abstract] [Full Text] [Related]

  • 11. New approaches to the removal of protein-bound toxins from blood plasma of uremic patients.
    Sarnatskaya VV, Yushko LA, Sakhno LA, Nikolaev VG, Nikolaev AV, Grinenko DV, Mikhalovsky SV.
    Artif Cells Blood Substit Immobil Biotechnol; 2007 Jan; 35(3):287-308. PubMed ID: 17573628
    [Abstract] [Full Text] [Related]

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 13. Displacement by anionic drugs of endogenous ligands bound to albumin in uremic serum.
    Mabuchi H, Nakahashi H.
    Ther Drug Monit; 1988 Nov; 10(3):261-4. PubMed ID: 3140432
    [Abstract] [Full Text] [Related]

  • 14. Tin-protein binding kinetics in normal and uremic plasma and its effect on dialysis fluxes.
    Maher JF, Montero G, Chieffo S.
    Trans Am Soc Artif Intern Organs; 1976 Nov; 22():149-54. PubMed ID: 951835
    [Abstract] [Full Text] [Related]

  • 15. Partial purification and characterization of the drug-binding-defect inducer in uremia.
    Lichtenwalner DM, Suh B, Lorber B, Rudnick MR, Craig WA.
    J Lab Clin Med; 1981 Jan; 97(1):72-81. PubMed ID: 7452082
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of equilibrium gel filtration chromatography for the study of protein binding of aluminum in normal and uremic sera.
    Bertholf RL, Wills MR, Savory J.
    Clin Physiol Biochem; 1985 Jan; 3(5):271-6. PubMed ID: 4053493
    [Abstract] [Full Text] [Related]

  • 17. Serum calcium in dialyzed uremic patients.
    Danesh BJ, Walker CH, Mathers NP.
    N Engl J Med; 1970 Jul 16; 283(3):155-6. PubMed ID: 5423156
    [No Abstract] [Full Text] [Related]

  • 18. Serum calcium in dialyzed uremic patients.
    Hattner RS, Jacobs J, Bernstein DS.
    N Engl J Med; 1970 Jul 16; 283(3):155. PubMed ID: 5423155
    [No Abstract] [Full Text] [Related]

  • 19. First evidence for accumulation of protein-bound and protein-free pyrraline in human uremic plasma by mass spectrometry.
    Odani H, Shinzato T, Matsumoto Y, Takai I, Nakai S, Miwa M, Iwayama N, Amano I, Maeda K.
    Biochem Biophys Res Commun; 1996 Jul 05; 224(1):237-41. PubMed ID: 8694819
    [Abstract] [Full Text] [Related]

  • 20. In-vitro study on the competitive binding of diflunisal and uraemic toxins to serum albumin and human plasma using a potentiometric ion-probe technique.
    Davilas A, Koupparis M, Macheras P, Valsami G.
    J Pharm Pharmacol; 2006 Nov 05; 58(11):1467-74. PubMed ID: 17132209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.